Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury

Acta Anaesthesiologica Scandinavica

Volumn 51, Issue 4, 2007, Pages 505-508

  Salluh, J I F ^a,b,c   Martins, G A R ^a   Santino, M S ^a   Araujo L V ^a   Freitas, G G ^a   Verdeal, J C R ^a  

^a Hospital Barra D'Or   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cerebral perfusion pressure; Jugular oxygen venous saturation; Shock; Terlipressin; Traumatic brain injury; Vasopressin

Indexed keywords

HYDROCORTISONE; NORADRENALIN; TERLIPRESSIN;

ADOLESCENT; ARTICLE; ASPIRATION; BRAIN PERFUSION; CASE REPORT; DRUG DOSE REDUCTION; DRUG INFUSION; EMERGENCY WARD; FLUID THERAPY; GLASGOW COMA SCALE; HUMAN; HYPOTENSION; INFLAMMATION; INJURY SEVERITY; MALE; PERFUSION PRESSURE; PRIORITY JOURNAL; SHOCK; STOMACH CONTENT; TRAFFIC ACCIDENT; TRAUMATIC BRAIN INJURY;

ACCIDENTS, TRAFFIC; ADOLESCENT; BLOOD PRESSURE; BRAIN INJURIES; CATECHOLAMINES; CEREBROVASCULAR CIRCULATION; DRUG RESISTANCE; FATAL OUTCOME; HUMANS; LYSINE VASOPRESSIN; MALE; MOTORCYCLES; MULTIPLE ORGAN FAILURE; NOREPINEPHRINE; OXYGEN; RESPIRATORY DISTRESS SYNDROME, ADULT; SEVERITY OF ILLNESS INDEX; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 33947252486     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2006.01252.x     Document Type: Article

References (15)

1. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359: 1209-10.
2. Leone M, Albanese J, Delmas A, Chaabane W, Garnier F, Martin C. Terlipressin in catecholamine-resistant septic shock patients. Shock 2004; 22: 314-9.
3. Chesnut RM, Marshall LF, Klauber MR et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993; 34: 216-22.
4. Pietropaoli JA, Rogers FB, Shackford SR, Wald SL, Schmoker JD, Zhuang J. The deleterious effects of intraoperative hypotension on outcome in patients with severe head injuries. J Trauma 1992; 33: 403-7.
5. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31: 1752-8.
6. Landry DW, Levin HR, Gallant EM et al. Vasopressin deficiency contributes to the vasodilatation of septic shock. Circulation 1997; 95: 1122-5.
7. Holmes CL, Walley KR. Vasopressin in the ICU. Curr Opin Crit Care 2004; 10: 442-8.
8. Bradley PG, Allen EK, Menon DK. Terlipressin for cerebral perfusion pressure support in a patient with septic shock. Anaesthesia 2004; 59: 619-20.
9. Yeh CC, Wu CT, Lu CH, Yang CP, Wong CS. Early use of small-dose vasopressin for unstable hemodynamics in an acute brain injury patient refractory to catecholamine treatment: a case report. Anesth Analg 2003; 97: 577-9.
10. Ballew KA. Vasopressin versus epinephrine for cardiopulmonary resuscitation. N Engl J Med 2004; 350: 2206-9.
11. Dunser MW, Mayr AJ, Tur A et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med 2003; 31: 1394-8.
12. Boerma EC, van der Voort PH, Ince C. Sublingual microcirculatory flow is impaired by the vasopressin-analogue terlipressin in a patient with catecholamine-resistant septic shock. Acta Anaesthesiol Scand 2005; 49: 1387-90.
13. Shawcross DL, Davies NA, Mookerjee RP et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology 2004; 39: 471-5.
14. Suzuki Y, Satoh S, Oyama H, Takayasu M, Shibuya M. Regional differences in the vasodilator response to vasopressin in canine cerebral arteries in vivo. Stroke 1993; 24: 1049-53.
15. Kam PC, Williams S, Yoong FF. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 2004; 59: 993-1001.